Microbix and Hunan Influenza JV Looking Doubtful
June 27, 2011 at 06:38 AM EDT
Microbix Biosystems, a Canadian company specializing in influenza vaccine technology, has put its China joint venture on hold. Three years ago, Microbix formed a flu vaccine JV with Hunan Biopharmaceutical, which would use Microbix’s technology to build Asia’s largest flu vaccine production facility. As the time to begin construction grew nearer, both sides wanted to amend the original contract. However, neither side would agree to the other’s changes. As a result, negotiations have stopped, and the future of the JV is in doubt. More details.... Stock Symbol: (TSX: MBX) Share this with colleagues:
